3 active not recruiting, 3 unknown, 2 terminated, 1 recruiting. 9 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Active not recruiting 3, Unknown 3, Terminated 2, Recruiting 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Advanced Gastric Carcinoma: new trials by email Literature Review of Advanced Gastric Carcinoma trials Research Report on Advanced Gastric Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors NKT3964, Paclitaxel, Doxorubicin - Solid Tumor, Advanced Solid Tumor | Phase 1 | Recruiting | NiKang Therapeutics, Inc. | 238 | 2024-09-19 | 2026-11-05 |
| A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors NKT3447 - Solid Tumor, Solid Tumor, Adult | Phase 1 | Terminated | NiKang Therapeutics, Inc. | 23 | 2024-02-23 | 2025-09-25 |
| IMM2902 in Patients With Advanced Solid Tumors Expressing HER2 IMM2902 - Advanced Solid Tumor, Advanced Lung Cancer | Phase 1 / Phase 2 | Unknown | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | 105 | 2022-02-15 | 2023-04-10 |
| Safety of XELOX Combined With GLS-010 and Lenvatinib in Advanced AFP-positive Gastric Cancer Patients Lenvatinib - First-line Treatment, Advanced Gastric Carcinoma | Phase 1 | Unknown | Tianjin Medical University Cancer Institute and Hospital | 18 | 2021-11-01 | 2022-02-03 |
| Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer Cisplatin, Elimusertib, Gemcitabine Hydrochloride - Advanced Bile Duct Carcinoma, Advanced Breast Carcinoma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 74 | 2021-08-25 | 2026-07-31 |
| Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines Biopsy Procedure, Biospecimen Collection, Diagnostic Imaging Testing - Advanced Colorectal Carcinoma, Advanced Digestive System Carcinoma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 10 | 2021-08-13 | 2026-08-21 |
| Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial Biopsy Procedure, Biospecimen Collection, Ceralasertib - Advanced Breast Carcinoma, Advanced Colon Carcinoma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 51 | 2021-08-09 | 2026-09-04 |
| A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Gastric Carcinoma Mitoxantrone Hydrochloride Liposome, intravenous injection - Advanced Gastric Carcinoma | Phase 1 | Terminated | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 21 | 2021-03-30 | 2024-03-07 |
| Dose Escalation Study of Liposomal Paclitaxel Plus Capecitabine in Chinese Patients With Advanced Gastric Carcinoma Liposomal paclitaxel plus capecitabine - Advanced Gastric Carcinoma | Phase 1 | Unknown | Nanjing Sike Pharmaceutical Co., Ltd. | 15 | 2009-04-01 | 2009-04-15 |
Stomach Neoplasms (4) · Endometrial Neoplasms (3) · Neoplasm Metastasis (3) · Ovarian Neoplasms (3) · Triple Negative Breast Neoplasms (3) · Colorectal Neoplasms (2) · Small Cell Lung Carcinoma (2) · Uterine Diseases (2) · Breast Neoplasms (1) · Carcinosarcoma (1) · Colonic Neoplasms (1) · Lung Neoplasms (1) · Mesothelioma, Malignant (1) · Penile Neoplasms (1) · Salivary Gland Neoplasms (1)
Neoplasms (5) · Neoplasms by Site (5) · Breast Diseases (4) · Digestive System Diseases (4) · Digestive System Neoplasms (4) · Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Gastrointestinal Diseases (4) · Gastrointestinal Neoplasms (4) · Genital Diseases (4) · Genital Diseases, Female (4) · Genital Neoplasms, Female (4) · Skin Diseases (4) · Skin and Connective Tissue Diseases (4) · Stomach Diseases (4)
BAY 1895344 (2) · Biopsy (2) · Specimen Handling (2) · 1,2-diaminocyclohexaneplatinum II citrate (1) · Capecitabine (1) · Cisplatin (1) · Doxorubicin (1) · Fluorouracil (1) · Gemcitabine (1) · Injections, Intravenous (1) · Irinotecan (1) · Leucovorin (1) · Magnetic Resonance Spectroscopy (1) · Paclitaxel (1) · Platinum (1)
National Cancer Institute (NCI) (3) · NiKang Therapeutics, Inc. (2) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (1) · ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1) · Nanjing Sike Pharmaceutical Co., Ltd. (1) · Tianjin Medical University Cancer Institute and Hospital (1)
United States (5) · China (3) · Canada (1) · South Korea (1)
Jieer Ying, Doctor (1) · Jin Li, Dr. (1) · Kanwal P Raghav (1) · Liza C Villaruz (1) · Mamta Parikh (1) · Yi Ba, MD (1)
UM1CA186688 (1), UM1CA186690 (1), UM1CA186717 (1)